Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Nankivell

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
BMC Cancer|July 18, 2024
Correction: PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trialPaul Nankivell, Piers Gaunt, Claire Gaunt, et al.
BMC Cancer|July 10, 2024
PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trialPaul Nankivell, Piers Gaunt, Claire Gaunt, et al.
Head & Neck|March 16, 2018
Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinomaKarl Payne, Rachel Spruce, Andrew Beggs, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|December 31, 2013
Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasiaPaul Nankivell, Hazel Williams, Keith Webster, et al.
Plos One|April 6, 2026
Referral to treatment times in the National Health Service of England: A five-year analysis of the impact of the COVID-19 Pandemic and socioeconomic deprivation and future implications for Ear, Nose and Throat service deliveryDimitrios Spinos, Thomas Beech, Jonathan Lee, et al.
Frontiers in Oncology|December 23, 2024
Clinical predictive models for recurrence and survival in treated laryngeal and hypopharyngeal cancer: a systematic review and meta-analysisAhmad K Abou-Foul, Janine Dretzke, Esther Albon, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|April 5, 2025
Utilisation of Near Infrared Autofluorescence in Parathyroid Identification During Thyroidectomy: A Systematic Review and Meta-Analysis of Randomised Controlled TrialsAzfar Javed, Abdullah Alburaiki, Neil Sharma, et al.
The Laryngoscope|June 27, 2020
Pretreatment High MCV as Adverse Prognostic Marker in Nonanemic Patients with Head and Neck CancerDaniele Borsetto, Jerry Polesel, Giancarlo Tirelli, et al.
BMJ Open|December 5, 2024
Systematic review of prognostic models for predicting recurrence and survival in patients with treated oropharyngeal cancerJanine Dretzke, Ahmad K Abou-Foul, Esther Albon, et al.
Critical Reviews in Oncogenesis|October 13, 2018
Surveillance of HPV-Positive Head and Neck Squamous Cell Carcinoma with Circulating and Salivary DNA BiomarkersDaniele Borsetto, Jordan Cheng, Karl Payne, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
BMC Cancer|July 18, 2024
Correction: PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trialPaul Nankivell, Piers Gaunt, Claire Gaunt, et al.
BMC Cancer|July 10, 2024
PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trialPaul Nankivell, Piers Gaunt, Claire Gaunt, et al.
Head & Neck|March 16, 2018
Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinomaKarl Payne, Rachel Spruce, Andrew Beggs, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|December 31, 2013
Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasiaPaul Nankivell, Hazel Williams, Keith Webster, et al.
Plos One|April 6, 2026
Referral to treatment times in the National Health Service of England: A five-year analysis of the impact of the COVID-19 Pandemic and socioeconomic deprivation and future implications for Ear, Nose and Throat service deliveryDimitrios Spinos, Thomas Beech, Jonathan Lee, et al.
Frontiers in Oncology|December 23, 2024
Clinical predictive models for recurrence and survival in treated laryngeal and hypopharyngeal cancer: a systematic review and meta-analysisAhmad K Abou-Foul, Janine Dretzke, Esther Albon, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|April 5, 2025
Utilisation of Near Infrared Autofluorescence in Parathyroid Identification During Thyroidectomy: A Systematic Review and Meta-Analysis of Randomised Controlled TrialsAzfar Javed, Abdullah Alburaiki, Neil Sharma, et al.
The Laryngoscope|June 27, 2020
Pretreatment High MCV as Adverse Prognostic Marker in Nonanemic Patients with Head and Neck CancerDaniele Borsetto, Jerry Polesel, Giancarlo Tirelli, et al.
BMJ Open|December 5, 2024
Systematic review of prognostic models for predicting recurrence and survival in patients with treated oropharyngeal cancerJanine Dretzke, Ahmad K Abou-Foul, Esther Albon, et al.
Critical Reviews in Oncogenesis|October 13, 2018
Surveillance of HPV-Positive Head and Neck Squamous Cell Carcinoma with Circulating and Salivary DNA BiomarkersDaniele Borsetto, Jordan Cheng, Karl Payne, et al.
Pageof 8